Association between omentin levels and insulin resistance in pregnancy

Experimental and Clinical Endocrinology and Diabetes

Volumn 122, Issue 3, 2014, Pages 163-166

  Aktas, G ^a   Alcelik, A ^a   Ozlu, T ^a   Tosun, M ^a   Tekce, B K ^a   Savli, H ^a   Tekce, H ^a   Dikbas, O ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

insulin resistance; omentin; pregnancy

Indexed keywords

ADIPOCYTOKINE; GLUCOSE; INSULIN; OMENTIN; UNCLASSIFIED DRUG; CYTOKINE; GLUCOSE BLOOD LEVEL; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; METABOLIC PARAMETERS; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; YOUNG ADULT; BLOOD; COMPARATIVE STUDY; HOMEOSTASIS; METABOLISM; MIDDLE AGED; THIRD TRIMESTER PREGNANCY;

ADULT; BLOOD GLUCOSE; CYTOKINES; DIABETES, GESTATIONAL; FEMALE; GPI-LINKED PROTEINS; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; LECTINS; MIDDLE AGED; PREGNANCY; PREGNANCY TRIMESTER, THIRD;

EID: 84896469163     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0034-1370917     Document Type: Article

References (21)

1. Schaffler A., Neumeier A., Herfarth H. et al. Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta: 2005; 1732 96 102 (Pubitemid 43267310)
2. Yang R. Z., Lee M. J., Hu H. et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab: 2006; 290 E1253 E1261 (Pubitemid 43847911)
3. Tan B. K., Adya R., Randeva H. S. Omentin: A Novel Link Between Inflammation, Diabesity, and Cardiovascular Disease. Trends Cardiovasc Med: 2010; 20 143 148
4. Cai R. C., Wei L., Di J. Z. et al. Expression of omentin in adipose tissues in obese and type 2 diabetic patients. Zhonghua yi xue za zhi: 2009; 89 381 384
5. Pan H. Y., Guo L., Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes research and clinical practice: 2010; 88 29 33
6. de Souza Batista C. M., Yang R. Z., Lee M. J. et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes: 2007; 56 1655 1661 (Pubitemid 46842600)
7. Dandona P., Aljada A., Chaudhuri A. et al. Metabolic syndrome - A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation: 2005; 111 1448 1454 (Pubitemid 40396812)
8. Senolt L., Polanska M., Filkova M. et al. Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann Rheum Dis: 2010; 69 1410 1411
9. Knopp R. H., Montes A., Warth M. R. Carbohydrate and lipid metabolism. Laboratory Indices of Nutritional Status in Pregnancy. Washington, D.C National Academy of Sciences: 1978; 35 88
10. Freinkel N., Phelps R. L., Metzger B. E. Intermediary metabolism during normal pregnancy. In: Sutherland H. W., Stowers J. M. (ed.). Carbohydrate Metabolism in Pregnancy and the Newborn. New York Springer-Verlag: 1979; 1 31
11. Burt R. L., Davidson I. W. Insulin half-life and utilization in normal pregnancy. Obstet Gynecol: 1974; 43 161 170
12. Berson S. A., Yalow R. S. Insulin antagonists and insulin resistance. In: Ellenberg M., Rifkin H. (ed.). Diabetes Mellitus: Theory and Practice. New York McGraw-Hill: 1970; 388 423
13. Orlik B., Madej P., Owczarek A. et al. Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome. Clin Endocrinol 2013 doi: 10.1111/cen.12381. [Epub ahead of print]
14. Tan B. K., Adya R., Farhatullah S. et al. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes: 2008; 57 801 808
15. Moreno-Navarrete J. M., Catalan V., Ortega F. et al. Circulating omentin concentration increases after weight loss. Nutr Metab: 2010; 7
16. Tan B. K., Adya R., Farhatullah S. et al. Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome. Diabetes: 2010; 59 3023 3031
17. Alcelik A., Tosun M., Ozlu M. F. et al. Serum Levels of Omentin in End-Stage Renal Disease Patients. Kidney Blood Press R: 2012; 35 511 516
18. Tan B. K., Pua S., Syed F. et al. Decreased plasma omentin-1 levels in Type 1 diabetes mellitus. Diab Med: 2008; 25 1254 1255
19. Yan P., Liu D., Long M. et al. Changes of Serum Omentin Levels and Relationship between Omentin and Adiponectin Concentrations in Type 2 Diabetes Mellitus. Exp Clin Endocr Diab: 2011; 119 257 263
20. Lewandowski K., Nadel I., Lewinski A. et al. Positive correlation between serum omentin and thrombospondin-1 in gestational diabetes despite lack of correlation with insulin resistance indices. Ginekol Pol: 2010; 81 907 912
21. Nielsen L. R., Ekbom P., Damm P. et al. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care: 2004; 27 1200 1201 (Pubitemid 38579790)